Stanislav Gobec

Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

Boris Brus, Urban Košak, Samo Turk et al. · Journal of Medicinal Chemistry · 2014 · 268 citations · Full text

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

Urban Košak, Boris Brus, Damijan Knez et al. · Scientific Reports · 2016 · 159 citations · Full text

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

Urban Košak, Boris Brus, Damijan Knez et al. · Journal of Medicinal Chemistry · 2017 · 151 citations · Full text

Combinatorial Chemistry, Scopolamine Model, Neurochemical Biomarkers +23

Endocrine Disruptome—An Open Source Prediction Tool for Assessing Endocrine Disruption Potential through Nuclear Receptor Binding

Katra Kolšek, Janez Mavri, Marija Sollner Dolenc et al. · Journal of Chemical Information and Modeling · 2014 · 150 citations

Drug Target, Pharmacotherapy, Endocrine Disruption Potential +18

A road map for prioritizing warheads for cysteine targeting covalent inhibitors

Péter Ábrányi‐Balogh, László Petri, Péter A. Szijj et al. · European Journal of Medicinal Chemistry · 2018 · 121 citations

Molecular Docking, Medicinal Chemistry, Covalent Inhibitors +10